102 related articles for article (PubMed ID: 20332677)
1. [Dendritic cell-based immunotherapy for hepatocellular carcinoma].
Nakamoto Y; Kaneko S
Gan To Kagaku Ryoho; 2010 Mar; 37(3):413-6. PubMed ID: 20332677
[TBL] [Abstract][Full Text] [Related]
2. Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety.
Nakamoto Y; Mizukoshi E; Tsuji H; Sakai Y; Kitahara M; Arai K; Yamashita T; Yokoyama K; Mukaida N; Matsushima K; Matsui O; Kaneko S
Clin Exp Immunol; 2007 Feb; 147(2):296-305. PubMed ID: 17223971
[TBL] [Abstract][Full Text] [Related]
3. Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization.
Nakamoto Y; Mizukoshi E; Kitahara M; Arihara F; Sakai Y; Kakinoki K; Fujita Y; Marukawa Y; Arai K; Yamashita T; Mukaida N; Matsushima K; Matsui O; Kaneko S
Clin Exp Immunol; 2011 Feb; 163(2):165-77. PubMed ID: 21087443
[TBL] [Abstract][Full Text] [Related]
4. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
5. [Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma].
Takekoshi H; Oyama R
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2845-8. PubMed ID: 2476966
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma.
Sun K; Wang L; Zhang Y
Cell Mol Immunol; 2006 Jun; 3(3):197-203. PubMed ID: 16893500
[TBL] [Abstract][Full Text] [Related]
7. [Transarterial immuno-embolization therapy in patients with hepatocellular carcinoma].
Eguchi H; Takeda T; Sakon M; Umeshita K; Ohzato H; Dono K; Gotoh M; Monden T; Monden M
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1665-7. PubMed ID: 9382502
[TBL] [Abstract][Full Text] [Related]
8. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
Yin XY; Wang L; Lu MD; Li BJ; Huang JF
Hepatogastroenterology; 2008; 55(81):155-9. PubMed ID: 18507097
[TBL] [Abstract][Full Text] [Related]
9. [Clinical effects of dendritic cells pulsed with autologous hepatoma cell lysates on the postoperative recurrence and metastasis of hepatocellular carcinoma].
Gao J; Chen M; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):432-5. PubMed ID: 15975277
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH
Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401
[TBL] [Abstract][Full Text] [Related]
11. [Changes in the immune function of dendritic cells (DC) derived from HBV-related hepatocellular carcinoma (HCC) patient's peripheral blood monocytes (PBMC) pulsed with tumor antigen].
Wong YQ; Qiu SJ; Tang ZY; Ye SL; Liu YK; Fan J; Sun RX; Zhao Y
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):339-42. PubMed ID: 15918966
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
[TBL] [Abstract][Full Text] [Related]
13. Palliative treatment of hepatocellular carcinoma with transcatheter arterial embolization.
Savastano S; Feltrin GP; Neri D; da Pian P; Chiesura-Corona M; Roman E; Battaglia G; Gerunda G; Lise M; Miotto D
Acta Radiol; 1993 Jan; 34(1):26-9. PubMed ID: 7678975
[TBL] [Abstract][Full Text] [Related]
14. Administration of dendritic cells in cancer nodules in hepatocellular carcinoma.
Kumagi T; Akbar SM; Horiike N; Kurose K; Hirooka M; Hiraoka A; Hiasa Y; Michitaka K; Onji M
Oncol Rep; 2005 Oct; 14(4):969-73. PubMed ID: 16142359
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma.
Cao DY; Yang JY; Yue SQ; Tao KS; Song ZS; Wang DS; Yang YL; Dou KF
Cell Immunol; 2009; 259(1):13-20. PubMed ID: 19545862
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of tumor-specific T-cell responses by transcatheter arterial embolization with dendritic cell infusion for hepatocellular carcinoma.
Mizukoshi E; Nakamoto Y; Arai K; Yamashita T; Mukaida N; Matsushima K; Matsui O; Kaneko S
Int J Cancer; 2010 May; 126(9):2164-74. PubMed ID: 19739081
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of hepatocellular carcinoma.
Korangy F; Höchst B; Manns MP; Greten TF
Expert Rev Gastroenterol Hepatol; 2010 Jun; 4(3):345-53. PubMed ID: 20528121
[TBL] [Abstract][Full Text] [Related]
18. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
[TBL] [Abstract][Full Text] [Related]
19. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
Hasegawa I; Hirashima N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
[TBL] [Abstract][Full Text] [Related]
20. [Transcatheter arterial embolization for advanced hepatocellular carcinoma--indications and limitations].
Nakamura H; Kawata S; Takamura M; Osuga K; Murakami T
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1509-15. PubMed ID: 11015994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]